story of the week
Immune Checkpoint Inhibitors for Papillary Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Are Immune Checkpoint Inhibitors a Valid Option for Papillary Renal Cell Carcinoma? A Multicentre Retrospective Study
Eur. J. Cancer 2020 Jul 09;136(xx)76-83, M de Vries-Brilland, M Gross-Goupil, V Seegers, E Boughalem, B Beuselinck, C Thibault, C Chevreau, S Ladoire, P Barthélémy, S Negrier, D Borchiellini, O Huillard, L Geoffrois, G Gravis, C Saldana, A Thiery-Vuillemin, B Escudier, A Ravaud, L AlbigesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.